In higher doses of 50 mg (which may be prescribed off-label), the average weight loss is 15.1% in 68 weeks, according to a separate study
It discontinued earlier weight-loss programs (GIP/GLP combinations) and is focusing on diabetes-related indications (resmetirom for NASH, for instance)
Its empirically answerable by randomized discontinuation trials
Basal insulin analogues (such as insulin glargine or insulin degludec) provide once-daily dosing with a lower risk of hypoglycaemia compared to older insulin formulations
86 A recent case report linked semaglutide (0.5 mg/wk) to a case of drug-induced systemic lupus erythematosus that developed within 3 months of treatment initiation and described systemic lupus erythematosuslike symptoms in a subset of patients using this medication, namely females older than 60 years, within the first month of treatment
For people managing diabetes, the goal is often to keep blood sugar within a specific range